Krabbe Disease Clinical Trial
Official title:
Diffusion Tensor Imaging (DTI) as a Tool to Identify Infants With Krabbe Disease in Urgent Need of Treatment
Verified date | May 2024 |
Source | University of Pittsburgh |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study is designed to learn about early brain development in children with Krabbe disease, and to use diffusion tensor imaging as an early diagnostic tool to identify newborns at risk for the disease.
Status | Active, not recruiting |
Enrollment | 100 |
Est. completion date | April 2027 |
Est. primary completion date | April 2027 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A to 17 Years |
Eligibility | Inclusion Criteria: 1. Positive newborn screening test (low galactocerebrosidase) 2. Infantile Krabbe Disease diagnosed by confirmatory low levels of residual enzyme by Dr. Wenger's Lysosmal Storage Diseases laboratory at Jefferson's Medical College (contracted by New York State) and/or carrier status established because of family history of Krabbe Disease. Patients have to be less than 6 weeks old at the time of the first assessment 3. Children at risk of developing motor disability Exclusion Criteria: 1. Diagnosis or physical signs of known genetic conditions or syndromes, serious medical or neurological conditions affecting growth and development (e.g., seizure disorder, diabetes, congenital heart disease) or sensory impairments such as vision or hearing loss 2. Children who may have suffered serious perinatal brain damage, children with birth weights less than 2000 grams and/or gestational ages of less than 34 weeks, or those with a history of intraventricular hemorrhage 3. Children who may have a contraindication for MRI (pacemaker, vascular stents, metallic ear tubes, other metal implants or braces). |
Country | Name | City | State |
---|---|---|---|
United States | UPMC Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
University of Pittsburgh | National Institute of Neurological Disorders and Stroke (NINDS) |
United States,
Escolar ML, Poe MD, Provenzale JM, Richards KC, Allison J, Wood S, Wenger DA, Pietryga D, Wall D, Champagne M, Morse R, Krivit W, Kurtzberg J. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005 May 19;352(20):2069-81. doi: 10.1056/NEJMoa042604. — View Citation
Provenzale JM, Escolar M, Kurtzberg J. Quantitative analysis of diffusion tensor imaging data in serial assessment of Krabbe disease. Ann N Y Acad Sci. 2005 Dec;1064:220-9. doi: 10.1196/annals.1340.040. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Diffusion tensor imaging (DTI) of corticospinal tracts | at birth, 1 year and 2 years of age | ||
Secondary | Motor development at birth, 1 year and 2 years of age | at birth, 1 year and 2 years of age | ||
Secondary | Analysis of DTI-Fractional Diffusion Anisotropy (FA) values of corticospinal tracts of newborns | at age (newborn-6 weeks), 12-months and 24-months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02993796 -
Krabbe Disease Global Patient Registry
|
||
Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
Active, not recruiting |
NCT04693598 -
Gene Transfer Clinical Trial for Krabbe Disease
|
Phase 1/Phase 2 | |
Terminated |
NCT00668564 -
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
|
Phase 2 | |
Not yet recruiting |
NCT06308718 -
Long-term Follow-up Study to Evaluate Safety and Efficacy of FBX-101 in Krabbe Patients
|
||
Active, not recruiting |
NCT02699190 -
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
|
||
Completed |
NCT01938014 -
Lysosomal Storage Disease: Health, Development, and Functional Outcome Surveillance in Preschool Children
|
||
Recruiting |
NCT03333200 -
Longitudinal Study of Neurodegenerative Disorders
|
||
Recruiting |
NCT05739643 -
Gene Transfer Clinical Trial for Infantile and Late Infantile Krabbe Disease Treated Previously With HSCT
|
Phase 1/Phase 2 | |
Recruiting |
NCT03047369 -
The Myelin Disorders Biorepository Project
|
||
Completed |
NCT01043640 -
Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
|
Phase 2 | |
Withdrawn |
NCT01425489 -
Biomarker for Krabbe Disease (BioKrabbe)
|